An interventional study of soft tissue augmentation in Implant Tissue Failure, Dental Implant Failed and Peri-Implantitis, sponsored by Universidad de Murcia. Recruiting at 1 site in Spain. Per ClinicalTrials.gov, last updated 2024-01-16.
Sponsored by Universidad de Murcia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 50 studies in Peri-Implantitis with a site in Spain — 16 open to participants now, 19 under way, none of them phase 3. Peri-Implantitis · Spain.
Among the 50 studies in Peri-Implantitis with a site in Spain, this one is the 19th largest by planned enrollment of the 27 interventional ones that give a count, is one of 5 that started in 2024, is one of 22 with no phase, reaches primary completion later than 4 of the 18 other live ones, and was the 34th registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →16 of the 50 studies in Peri-Implantitis with a site in Spain are open now. Recruiting first, the newest first:
Arrow Development · Sites in Spain
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain · Sites in Spain
Ages up to 90 · Healthy volunteers
Bioteck S.p.A. · Sites in Spain
Ages 25–65
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+ · Healthy volunteers
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+ · Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
50 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 5 started in 2024.
This study's planned enrollment of 30 is below the median of 40 across 196 interventional studies indexed under Peri-Implantitis.
Median enrollment 37 across the 27 interventional studies, 117 across the 22 observational. Of the 26 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 50 have an industry lead sponsor. The 10 most frequent:
Universidad de Murcia is the lead sponsor of 81 studies on the registry; 18 are open to participants now.
Universidad de Murcia has 2 studies filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
5 of the studies in Peri-Implantitis with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07557459Arrow DevelopmentAccess to Probing and Peri-implant Diseases | 2027-05 |
| NCT07638969Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, SpainOccurrence of Peri-Implant Complications: A Multifactorial Cross-Sectional Study | 2027-07-01 |
| NCT07590037University of BarcelonaComparison of Anesthetic Efficacy and Safety Between Inferior Alveolar Nerve Block and the Infiltrative Technique for the Treatment of Peri-implant Diseases in Posterior Mandibular Implants | 2027-09 |
| NCT07694323University of BarcelonaPatient Perspectives Throughout Peri-Implantitis Treatment | 2027-09-03 |
| NCT07680491Bioteck S.p.A.Non-surgical Treatment of Peri-implant Pockets With H42 | 2027-09-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 50 studies in Peri-Implantitis with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Peri-implant mucositis is one of the most common peri-implant diseases. It was reported in more than 20% of the subjects rehabilitated with dental implants (Lee et al. 2017; Rodrigo et al. 2018; Wada et al. 2019). Furthermore, a significant association was found between peri-implant mucositis, and smoking, implant maintenance and peri-implant soft tissue characteristics (Wada et al. 2019).
Soft tissue quality and volume of the peri-implant mucosa are considered important factors in the prognosis of osseointegrated implants. Linkevicius et al. showed that if its soft tissue thickness was less than 2 mm, crestal bone loss might occur (Linkevicius et al. 2009). In addition, when soft tissue width was evaluated, a wider soft tissue band was related to minimal bone remodeling (Linkevicius et al. 2015). Lin et al. reported in a systematic review and meta-analysis that a lack of keratinized tissue (KT) around osseintegrated implants was associated with plaque accumulation, peri-implant tissue inflammation, soft tissue recession and attachment loss (Lin et al. 2013). Moreover, recent studies established the need of a minimal band of 2 mm of KT around osseointegrated implants, and showed that a band less than 2 mm was associated with more brushing discomfort, plaque accumulation, tissue inflammation and marginal bone apical displacement, concluding that a KT>2 mm had a protective effect on peri-implant tissues (Souza et al. 2015, Perussolo et al. 2018, Monje et al. 2019). Furthermore, peri-implant tissue diseases have also been related to an irregular compliance in situations of lack of KT (Monje et al. 2019).
In the presence of peri-implant horizontal and/or vertical soft tissue deficiencias, soft tissue augmentation has been considered a priority, even prior or instead of bone augmentation (Burkhardt et al. 2008, Zucchelli et al. 2013).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
implant with soft tissue recession Plaque index score less than 30% No relevant systemic disease Smokers (Less than 20 cigars/day)
Exclusion Criteria:
Pregnancy-Lactation Relevant systemic disease
LRF, Moreno and Caffesse, 2016
Procedure: soft tissue augmentation
FGG, Sullivan and Atkins, 1968, Langer and Sullivan, 1989
Procedure: soft tissue augmentation
Laterally Rotated Flap: A Split-thickness recipient bed on the buccal and mesial aspects of the implant was prepared, resulting in a firm attached bleeding area. The extension of the incisions towards the palate and the distance between them are dependent on the amount of keratinized tissue graft needed for each particular case. Habitually, the keratinized tissue is taken from the adjacent crest; however, if needed to displace more tissue, the incisions may be extended into the palatal tissue. The flap was prepared partial thickness, and released apically from the periosteum to allow passive displacement, and suturing without tension. It was latero-mesially displaced with a 90º rotation. The pedicle was sutured to the recipient bed. Control group: The surgical procedure followed the design proposed by Sullivans \& Atkins 1968 for soft tissue augmentation around teeth and modified by for application around oseointegrated dental implants.
Change in soft tissue 6months after procedure
The amount of soft tissue gained in millimeters will be measured before and after
Time frame: 1 year
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Apr 2024; primary completion for Sep 2024, 5 months later.
Of 121 non-industry interventional studies with no phase under Peri-Implantitis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 46. This study's planned 5 months is below that.
Counting every sponsor, half of 128 studies reached it within 26 months; a quarter within 12 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de Murcia